CC
ALXN

Centiva Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Centiva Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-46,039
Closed -$8.46M – 1796
2021
Q2 		$8.46M Sell
46,039
-11,158
-20% -$1.92M 0.2% 91
2021
Q1 		$8.75M Buy
57,197
+39,697
+227% +$6.14M 0.33% 52
2020
Q4 		$2.73M Buy
+17,500
New +$2.25M 0.11% 113
2020
Q2 		– Sell
-16,757
Closed -$1.5M – 858
2020
Q1 		$1.5M Buy
16,757
+10,285
+159% +$1.01M 0.07% 172
2019
Q4 		$700K Buy
6,472
+466
+8% +$49.8K 0.03% 348
2019
Q3 		$588K Buy
+6,006
New +$677K 0.04% 288

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Centiva Capital's ALXN Position: Q3 2021 in Review

Centiva Capital sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 46,039 shares — an estimated $8.46M sold.

Centiva Capital first reported a position in ALXN in Q3 2019 and held it in 6 quarters. The position peaked at $8.75M in Q1 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Centiva Capital reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Centiva Capital sold 46,039 Alexion Pharmaceuticals shares in Q3 2021, an estimated $8.46M.
  • Centiva Capital first reported a position in Alexion Pharmaceuticals in Q3 2019 and held it in 6 quarters.
  • Centiva Capital's Alexion Pharmaceuticals position peaked at $8.75M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Centiva Capital's 13F filing for Q3 2021, filed 15 Nov 2021.